Crystalline Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Crystalline Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45,100	Closed	-$1.62M	–	155
2022 Q4	$1.62M	Buy	+45,100	New	+$1.13M	0.82%	33

Crystalline Management's IMGO Position: Q1 2023 in Review

Crystalline Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 45,100 shares — an estimated $1.62M sold.

Crystalline Management first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $1.62M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Crystalline Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Crystalline Management sold 45,100 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $1.62M.
Crystalline Management first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
Crystalline Management's Imago BioSciences, Inc. Common stock position peaked at $1.62M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Crystalline Management's 13F filing for Q1 2023, filed 9 May 2023.